Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Envista (NVST) to $30 from $40 and keeps an Outperform rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia (IQV) and R1 RCM (RCM), the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVST:
